ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
1-Year Return
45.88%
This Quarter Return
-0.76%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$185M
AUM Growth
+$125M
(+209%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
68.82%
Top 10 Holdings %
Top 10 Hldgs %
67.37%
Holding
37
New
12
Increased
18
Reduced
–
Closed
7
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$15.1M |
| 2 |
Insmed
INSM
|
$14.7M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$12M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$9.27M |
| 5 |
Inogen
INGN
|
$9.24M |
Top Sells
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$3.41M |
| 2 |
Illumina
ILMN
|
$2.58M |
| 3 |
Heron Therapeutics
HRTX
|
$1.66M |
| 4 |
Penumbra
PEN
|
$1.65M |
| 5 |
CVS Health
CVS
|
$1.02M |
Sector Composition
| 1 | Healthcare | 89.71% |
| 2 | Industrials | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Adaptive Biotechnologies
ADPT
$1.93B
| $1.09M | 0.59% |
+22,500
| New | +$1.09M |
|
27
AbbVie
ABBV
$375B
| $1.05M | 0.57% |
+14,406
| New | +$1.05M |
|
|
ATRS
28
DELISTED
Antares Pharma, Inc.
ATRS
| $906K | 0.49% |
+275,425
| New | +$906K |
|
|
HMSY
29
DELISTED
HMS Holdings Corp.
HMSY
| $829K | 0.45% |
+25,598
| New | +$829K |
|
30
Ascendis Pharma
ASND
$12.4B
| $438K | 0.24% |
+3,800
| New | +$438K |
|
31
Alkermes
ALKS
$4.88B
| – | – |
-27,673
| Closed | -$1.01M |
|
32
Alnylam Pharmaceuticals
ALNY
$59.3B
| – | – |
-8,754
| Closed | -$818K |
|
|
33
CVS Health
CVS
$94.4B
| – | – |
-28,680
| Closed | -$1.02M |
|
|
34
Heron Therapeutics
HRTX
$199M
| – | – |
-67,909
| Closed | -$1.66M |
|
|
35
Illumina
ILMN
$15.6B
| – | – |
-8,551
| Closed | -$2.58M |
|
|
36
Penumbra
PEN
$11B
| – | – |
-11,254
| Closed | -$1.65M |
|
|
AERI
37
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-71,675
| Closed | -$3.41M |
|